Site Tour
A-Z Index
Librarians
Newsletter
Subscriptions
About
Advisory Board
Contact Us
Help
Blog
Log In
|
Log In via Athens
select
Disable Autosuggest
Advanced Search
About Search
All
Pediatric Only |
Images & Videos Only
Hadzic's Regional Anesthesia
>
Part IV. New and Emerging Concepts in Peripheral Nerve Blocks: Equipment and Practice
>
Chapter 48. Equipment for Continuous Peripheral Nerve Blocks
Holly Evans, MD, Karen C. Nielsen, MD, Roy A. Greengrass, MD, Susan M. Steele, MD
Equipment for Continuous Peripheral Nerve Blocks: Introduction
Topics Discussed:
continuous peripheral nerve block; peripheral nerve blocks.
Excerpt:
"
Continuous peripheral nerve blocks (CPNBs) provide many advantages in the perioperative period.
1
These techniques provide the flexibility to prolong intraoperative anesthesia while avoiding the risks and side effects of general anesthesia. After surgery, CPNBs offer extended postoperative analgesia. When compared with parenteral opioid analgesia, CPNBs are associated with superior analgesia, reduced opioid consumption, and decreased opioid-related side effects such as postoperative nausea and vomiting, sedation, and respiratory depression.
212
Analgesia results are of a quality similar to epidural anesthesia results; however, CPNBs are associated with less hypotension, urinary retention, pruritus, and mobility restrictions than epidural analgesia.
8,1315
There is also evidence supporting the beneficial effect of CPNBs on postoperative sleep patterns and cognitive function
16,17
as well as early rehabilitation.
8,9
Concurrent sympathectomy is ideal after microvascular surgery, reimplantation, and free-flap surgery
18,19
as well as for treatment of accidental intraarterial drug injection.
2022
Extended analgesia can also be provided for chronic pain patients
23
and those requiring palliation of terminal illness.
24
Despite these benefits, CPNBs have historically been relatively underused techniques. These reasons for the underutilization were multifactorial; however, inadequate CPNB equipment likely contributed. Until recently, there had been few commercially..."
The content above is only an excerpt. For full access, log into an existing user account below,
purchase
an annual subscription, or
purchase
a short-term subscription to the complete website.
Subscriber Log In:
Username:
Password:
Forgot your Username/Password?
Or
Copyright © The McGraw-Hill Companies. All rights reserved.
Privacy Notice
. Any use is subject to the
Terms of Use
and
Notice
.
Your IP address is 38.107.179.223